GI Dynamics, a leader in non-surgical treatments for type 2 diabetes and obesity, announced data which support the safety and efficacy of the EndoBarrier™ Gastrointestinal Liner for pre-surgical weight loss treatment, along with a positive effect on glucose homeostasis in morbidly obese patients with type 2 diabetes mellitus.


Click Here To Read Entire Article... (http://us.rd.yahoo.com/dailynews/rss/search/bariatric+surgery+news/SIG=11nbvme6g/*http%3A//www.medicalnewstoday.com/articles/169034.php)